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Abstract Transfection of sense cDNA of N-acetylglucosami-
nyltransferase V (GnTV) into H7721 human hepatocellular car-
cinoma cells resulted in the decreased expression of surface
sialyl Lewis X (SLex), a sialylated fucose-containing antigen.
The enzymatic mechanisms were speculated to be the concom-
itantly decreased expression of K1,3-fucosyltransferase (FucT)-
III, -VI, -VII and the branching enzyme of O-glycans, core
2-L1,6-N-acetylglucosaminyltransferase (C2GnT)-I, -II. These
two glycosyltransferase families were suggested to be the key
enzymes in the synthesis of SLex. The expression of K2,3-sia-
lyltransferase (ST3)-IV, but not ST3-I, -II and -III was elevated
by sense GnTV. However, it did not cause the increase of SLex
synthesis. Transfection of antisense GnTV into H7721 cells
showed entirely opposite e¡ects on the expression of above-
mentioned SLex and glycosyltransferases as the sense GnTV.
1 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Alteration in the glycan structure on cancer cell surface is
closely related to malignant behaviors such as invasion and
metastasis. At least two surface glycan structures are fre-
quently reported to closely associate with cancer metastasis.
One is the N-acetylglucosamine (GlcNAc) L1,6-mannose-K1,6
branching structure on N-glycan of glycoproteins [1,2], which
is synthesized by N-acetylglucosaminyltransferase V (GnTV),
a well-known cancer-associated enzyme which is upregulated
in many cancers [1^6]. We found that the in vitro metastatic
potential (cell adhesion to laminin, cell migration and inva-
sion through arti¢cial membrane) of a human hepatocarcino-
ma cell line, H7721, was promoted and attenuated upon
transfection of the sense and antisense cDNAs of GnTV
respectively [7]. Moreover, transfection of oncogene (H-ras
or v-sis) or anti-metastasis gene (nm23-H1) into H7721 cells
resulted in the concomitant increase or decrease, respectively,
in both GnTV expression and the metastatic potential [8,9].
The upregulation of GnTV expression is always accompanied
by the increase in the amount of its product, L1,6-GlcNAc
branch of N-glycans on the cell surface, indicating that the
e¡ect of GnTV is very likely mediated by this structure [7^9].
A second type of glycan structure related to metastasis is sialyl
Lewis sugar antigens, including sialyl Lewis X (SLex) [sialic
acid (SA)-K2,3-Gal-L1,4 (fucose-K1,3) GlcNAc-] ; sialyl dimer-
ic (difucosyl) Lewis X (SDLex) [SA-K2,3-Gal-L1,4 (fucose-
K1,3) GlcNAc-L1,3-Gal-L1,4 (fucose-K1,3) GlcNAc-L1,3-]
and sialyl Lewis A (SLea) [SA-K2,3-Gal-L1,3 (fucose-K1,4)
GlcNAc-]. They are mainly located in the termini of glycans
in glycolipids and O-glycans of glycoproteins, and also in the
outer chains of N-glycans. Their sialylation and fucosylation
steps are catalyzed by K2,3-sialyltransferase (K2,3-ST) and
K1,3-fucosyltransferase (K1,3-FucT) respectively. Sialyl Lewis
antigens are supposedly involved in the process of cancer
metastasis, since these compounds serve as ligands of E- or
P-selectin expressed on the surface of vascular endothelial
cells. Thus, they could mediate the adhesion of malignant cells
to vascular endothelium [10,11]. Patients with cancer cells
highly expressing SLex or SLea have a signi¢cantly higher
risk to develop hematogenous metastasis [12^14]. Our group
demonstrated that surface SLex was upregulated on H7721
cells upon transfection of the metastasis-promoting gene
c-erbB2/neu [15], or treatment of epidermal growth factor
(EGF) and phorbol ester [16]. It was downregulated by meta-
stasis-suppressive gene nm23H1 [17], all-trans retinoic acid
and cyclic adenosine monophosphate (AMP) [16]. In addition,
transfection of K1,3-FucT-VII into H7721 cells to increase the
synthesis of SLex antigen led to the enhancement of the meta-
static potential [15].
However, the relation between GnTV and K1,3-FucT or
their products, L1,6-GlcNAc branch and sialyl Lewis antigens
is still unresolved. Are these two enzymes or two products
independent of each other in the development of cancer meta-
stasis? Theoretically, the increased antennary (outer chain)
number of N-glycans by GnTV should provide more sub-
strates for the synthesis of sialyl Lewis antigens at the chain
termini, resulting in the increase of these antigens on the cell
surface. In the present investigation, the expression of surface
SLex was determined after H7721 cells were transfected with
sense or antisense cDNA of GnTV, since SLex is the predom-
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inant Lewis antigen on H7721 cell surface [15,17]. To our
surprise, it was found that sense GnTV reduced, while anti-
sense GnTV enhanced the expression of SLex. Then the e¡ect
of GnTV on the expressions of K1,3-FucT and cytidine
monophosphate-N-acetylneuraminate:L-galactoside K2,3-sia-
lyltransferase (ST3Gal), two glycosyltransferase families di-
rectly involved in SLex synthesis, was studied. In addition,
core 2-L1,6-N-acetylglucosaminyltransferase (C2GnT), a gly-
cosyltransferase needed for the branch formation of O-glycans
in glycoproteins was also investigated. It has been reported to
be a critical enzyme for the synthesis of SLex precursor [18],
and SLex located predominantly at the branching termini of
O-glycans.
2. Materials and methods
2.1. Materials
H7721 cell line was obtained from the Institute of Cell Biology,
Academia Sinica. RPMI-1640 medium and Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM) were purchased from Gibco/BRL. KM93
(anti-SLex monoclonal antibody) was a product of Seikagaku Com-
pany in Japan. Lectin Maackia amurensis agglutinin (MAA) and
Sambucus nigra agglutinin (SNA), £uorescein isothiocyanate
(FITC)-conjugated second antibodies (goat anti-mouse IgM) and
horseradish peroxidase (HRP) were purchased from Sigma. Trizol
and AMV reverse transcriptase were from Promega. Other reagents,
including Taq enzyme, RNase inhibitor, deoxyribonucleoside triphos-
phate (dNTP), oligo(dT)-18 were commercially available in China.
The plasmid containing sense cDNA of GnTV (pcDNA3FluHuTV,
7.75 kb) was a kind gift from Prof. Pierce at the University of Geor-
gia, USA. The characterization of this plasmid and the construction
of antisense cDNA of GnTV were described in our previous papers
[19,20]. The constructs containing sense and antisense cDNA of
GnTV, named GnTV-S and GnTV-AS respectively, and the vector
pcDNA3 were transfected into H7721 cells using the electroporation
method as described previously [19,20]. The GnTV-S-transfected cells
(GnTV-S/H7721) were characterized by the appearance of the tran-
script of exogenous GnTV-S cDNA and the increase of GnTV activ-
ity. Similarly, the cells transfected with GnTV-AS (GnTV-AS/H7721)
were characterized by the appearance of the transcript of GnTV-AS
cDNA, the decrease of endogenous GnTV mRNA and the GnTV
activity [19,20].
2.2. Cell culture and treatment
Cells were cultured at 37‡C, 5% CO2 in RPMI-1640 medium con-
taining 10% fetal calf serum (FCS), penicillin and streptomycin as
previously described [19,20].
2.3. Detection of Lewis antigen SLex with £ow cytometry
The cells (1U106) were detached with 2 mM ethylenediamine tetra-
acetic acid (EDTA), washed and resuspended in phosphate-bu¡ered
saline (PBS) containing 1% bovine serum albumin (BSA), then incu-
bated with 1:50 diluted monoclonal antibody to SLex (KM93) for 30
min at 4‡C. After being washed twice, the cells were incubated for 45
min at 4‡C with 1:200 diluted FITC-conjugated secondary antibody,
then the cells were washed again and 1U104 cells/sample were sub-
jected to £ow cytometry for £uorescence analysis [15^17]. A ‘(3)
Control’ sample without KM93 was set up in each run to normalize
the assay condition. Fluorescence-activated cell spectra (FACS) were
drawn automatically, and the left or right shift of the curve indicated
the decrease or increase of the mean £uorescence intensity (MFI)
respectively, as indicated by the ‘M1’ bar in the ¢gures.
2.4. Determination of the expression of glycosyltransferase mRNAs
with reverse transcriptase-polymerase chain reaction (RT-PCR)
Total cell RNA was extracted with Trizol and the complementary
DNAs (cDNAs) were synthesized with oligo(dT)-18 primer and AMV
reverse transcriptase from 3 Wg total RNA. The RT-PCR was per-
formed in 50 Wl of reaction mixture containing 5 Wl cDNA, 0.2 WM of
the primer pair of glycosyltransferases or L-actin (internal standard)
according to the manual. The cDNA was subjected to denaturation at
95‡C for 5 min, followed by 28 cycles (94‡C, 61.5‡C and 72‡C, 1 min
for each) of PCR, and incubated at 72‡C for 10 min and 4‡C for
5 min. Then 10 Wl products were applied to agarose gel electrophoresis.
The ampli¢ed DNA bands were scanned and the photographs were
analyzed with NIH Image software. The semiquantitative data were
obtained by the intensity ratios of the glycosyltransferase bands to the
L-actin band. For each glycosyltransferase, three experiments were
performed and the results were reproducible. The primers were as
follows: FucT-III F: 5P-CCTCCCGACAGGACACCACTCC-3P, R:
5P-GCGTCCGTACACGTCCACCTGG-3P [21]; FucT-VI F: 5P-AA-
TGGGTCCCGCTTCCCAGACAG-3P, R: 5P-GCGTCCGTACACG-
TCCACCTTG-3P [21]; FucT-VII F: 5P-CACCTCCGAGGCATCTT-
CAACTG-3P, R: 5P-CGTTGGTATCGGCTCTCATTCATG-3P [21];
ST3Gal-I F: 5P-TATGGGCCTGAGATAGACAGTCAC-3P, R: 5P-
GATCCGGATTTTATTGATGGAGGC-3P [21]; ST3Gal-II F: 5P-
GAGAACATGGATCTTCCACCGG-3P, R: 5P-GGCTGGGTTGT-
AGATCTGGACC-3P [21]; ST3Gal-III F: 5P-ATGGAGGCGTTC-
TTGCCAACAAG-3P, R: 5P-ATGCGAACGGTCTCATAGTAGTG-
3P [21] ; ST3Gal-IV F: 5P-TTGAACAATGCCCCAGTGG- CTGG-
3P, R: 5P-TCTTGGGAGACATTATGGCCTGAC-3P [21]; cytidine
monophosphate-N-acetylneuraminate:L-galactoside K2,6-sialyltrans-
ferase (ST6Gal)-I F: 5P-GAGAGCATTAGGACCAAGGCTGG-3P,
R: 5P-ACGTCAGTCTTGCGCTTGGATGG-3P [21]; C2GnT-I F:
5P-GCAATGAGTGCAAACTGGAAGT-3P, R: 5P-AATTGCCCGT-
AATGGTCAGTGTT-3P [22]; C2GnT-II F: 5P-TCAGGGGTCAC-
CCGAGGGGACCAAG-3P, R: 5P-CTCCACCTCTTCTTTGCTCA-
GTGG-3P [23]; L-actin F: 5P-GATATCGCCGCGCTCGTCGTCG-
AC-3P, R: 5P-CAGGAAGGAAGGCTGGAAGA- GTGC-3P [21].
2.5. Analysis of K2,3-sialyl and K2,6-sialyl residues at the glycan
terminal of cell protein
Cells were homogenized in HEPES bu¡er (pH 7.2) containing 2%
Triton X-100 with a brief soni¢cation, and centrifuged at 1000Ug at
4‡C for 15 min. Protein concentration was determined by Lowry’s
method [24]. Western blot was performed with a modi¢ed method
of Marone et al. [25] as described in our previous papers [9,15]. 60
Wg of the protein samples was separated by 6% sodium dodecyl sul-
fate^polyacrylamide gel electrophoresis (SDS^PAGE) and electroblot-
ted onto a polyvinylidene di£uoride (PVDF) membrane. The mem-
brane was blocked with 5% fat-free dried milk in PBS/0.05% Tween-
20 at 4‡C overnight and then incubated for 3 h with 1:100 dilution of
MAA-HRP or SNA-HRP in 5% fat-free dried milk/0.05% Tween-20
in PBS. The lectin-HRP conjugates were prepared by the method of
Wilson and Nakane [26]. Finally, the membrane was stained with the
enhanced chemiluminescence (ECL) reagent and put under X-ray ¢lm
for exposure. Three experiments were performed and the results were
reproducible.
3. Results
3.1. Expression of surface SLex on GnTV-S- and
GnTV-AS-transfected H7721 cells
Fig. 1 shows the expression of surface SLex as determined
by £ow cytometry. The mock (vector)-transfected H7721 cells
expressed a moderate amount of SLex. On the surface of
GnTV-S-transfected cells, the amount of SLex was decreased
to 45.4% of the ‘Mock’ value (P6 0.01). In antisense trans-
fected cells, on the other hand, it was elevated to 177.3%
compared to the ‘Mock’ cells (P6 0.01).
3.2. E¡ect of GnTV on the expressions of K1,3-FucT subtypes
Up to date, six subtypes of human K1,3-FucTs have been
cloned [27^32]. Four of them, K1,3-FucT-III, -V, -VI, -VII
e⁄ciently fucosylate sialylated acceptors and produce sialyl
Lewis antigens, while K1,3-FucT-V and -IX prefer neutral ac-
ceptors and form non-sialyl Lewis antigens as their products.
K1,3-FucT-III has both K1,3 and K1,4 fucosylation activities,
leading to synthesis of both K1,3-fucosyl-containing Lex or
SLex, and K1,4-fucosyl-containing SLea, while K1,3-FucT-
VII catalyzes the synthesis of SLex only. The gene for K1,3-
FucT-V was reported to be a silent gene and rarely expressed
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in tissue [33]. In untreated parent H7721 cells, K1,3-FucTs
mRNA appear in order IVs IIIsVIsVIIs IX, but the
main enzymes responsible for SLex synthesis are considered
to be K1,3-FucT-VI and -VII [34]. Therefore, the e¡ects of
GnTV on the expressions of K1,3-FucT-III, -VI and -VII
were studied.
In Fig. 2, the expressions of K1,3-FucT-III, -VI and -VII in
the cells are shown as determined by using RT-PCR. The
products of K1,3-FucT-III, -VI, -VII and L-actin were 521,
534, 497 and 789 bp, respectively, in consistency with the
reported lengths [21]. In mock-transfected cells, the expres-
sions of K1,3-FucT were IIIsVIsVII, a result compatible
with that using real-time PCR [34]. Interestingly, the expres-
sions of all the three assayed K1,3-FucTs were signi¢cantly
decreased in GnTV-S/H7721 cells (P6 0.01), representing
only 37.6, 45.0 and 52.5% of the ‘Mock’ levels respectively.
On the other hand, expressions of K1,3-FucT-III, -VI and
-VII were remarkably elevated in GnTV-AS/H7721, up to
185.2, 223.0 and 187.5% of the ‘Mock’ value, respectively
(P6 0.01).
3.3. E¡ect of GnTV on the expressions of STs
STs are divided in four speci¢c subfamilies based on their
substrate speci¢cities and the types of the formed sialyl link-
ages in the products (such as K2,3, K2,6 and K2,8) [35,36]. In
this investigation we concentrated to study the expression of
ST3Gal because of its critical role in the synthesis of SLex.
The ST3Gal subfamily transfers the sialyl group from cytidine
monophosphate-N-acetylneuraminate to the galactose residue
of glycans, forming a K2,3 linkage. ST3Gal can be further
divided into ¢ve subtypes. The substrates of types I and II
are the Gal-L1,3-N-acetylgalactosamine (GalNAc) sequence
on O-glycans and glycolipids respectively, while the preferred
substrates of ST3Gal-III and -IV are Gal-L1,3-GlcNAc- (pre-
cursor of SLea) and Gal-L1,4-GlcNAc- (precursor of SLex),
respectively. Type V was evidenced as a ganglioside GM3
synthase. The expressions of types I^IV were studied in
GnTV-S/H7721 and GnTV-AS/H7721 cells.
In Fig. 3 the expression levels of ST3Gal-I, -II, -III, -IV in
the cells are shown as determined by using RT-PCR. The
products of ST3Gal-I, -II, -III, and -IV were 543, 483, 529,
Fig. 1. Alteration of surface SLex expression on GnTV-S/H7721 and GnTV-AS/H7721 cells. A: FACS of SLex antigen. B: Relative expressions
of SLex antigen in di¡erently transfected cells (set the MFI value of ‘Mock’ as 100%). *: P6 0.01; n=3. (3) Control: Sample without the ad-
dition of KM93; Mock: H7721 cells transfected with pcDNA3 vector; GnTV-S: H7721 cells transfected with pcDNA3/GnTV-S plasmid;
GnTV-AS: H7721 cells transfected with pcDNA3/GnTV-AS plasmid. SLex : sialyl Lewis X. The experimental procedure was described in Sec-
tion 2.
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and 503 bp, also in agreement with the reported lengths [21].
Only ST3Gal-IV was expressed in an apparent amount. Its
level of expression varied so that it was increased to 216.7%
in GnTV-S/H7721 and decreased to 25.3% in GnTV-AS/
H7721 cells when compared with the controls.
In order to study whether the change of ST expression in
GnTV-S- and GnTV-AS-transfected cells was speci¢c for the
ST3Gal subfamily, the expression of ST6Gal as a control
glycosyltransferase for ST3Gal was also observed after the
transfection of GnTV-S and GnTV-AS. To date, two sub-
types, ST6Gal-I [35,36] and ST6Gal-II [37] were reported.
The ubiquitously expressed ST6Gal-I was selected for study.
The level of ST6Gal-I expression was the same in GnTV-S-,
GnTV-AS- and mock-transfected cells (data not shown).
3.4. E¡ect of GnTV on the amount of K2,3- and K2,6-sialyl
residues at the glycan termini of cell proteins
We next studied whether the alteration of ST3Gal-IV
expression brings about an expected change in the amount
of sialyl residues on surface glycans (Fig. 4). Results by using
HRP labeled MAA and SNA as speci¢c probes for K2,3- and
K2,6-linked sialyl residues [38,39] showed that the staining
intensity of HRP-SNA (speci¢c for K2,6-SA) was higher
than that of HRP-MAA (speci¢c for K2,3-SA) in all three
types of the transfected cells. The intensity of K2,3-SA
was approximately doubled on GnTV-S-transfected cells
(P6 0.01), but was decreased to about the half level on
GnTV-AS-transfected cells (P6 0.01) as compared to the
‘Mock’ cells. These ¢ndings were consistent with the results
concerning the expression of ST3Gal-IV in the same cells. The
results suggest that the increased and decreased terminal K2,3-
SA residues on glycoproteins on GnTV-S/H7721 and GnTV-
AS/H7721 cells, respectively, were the consequence of the al-
tered expression of ST3Gal-IV. On the other hand, the inten-
sity of K2,6-SA showed no apparent alteration among di¡er-
ently transfected cells.
3.5. E¡ect of GnTV on the expressions of C2GnT subtypes
C2GnT is a family of glycosyltransferases that catalyze the
synthesis of the branching core 2 and core 4 of O-glycans
[40,41]. These enzymes transfer the GlcNAc group from
UDP-GlcNAc to the innermost GalNAc residue in the se-
quence of Gal-L1,3-GalNAc-Ser/Thr (precursor of core 2) or
GlcNAc-L1,3-GalNAc-Ser/Thr (precursor of core 4) and form
a branching GlcNAc-L1,6-GalNAc linkage. In this study we
Fig. 2. Analysis of the expressions of K1,3-FucT-III, -VI and -VII
in GnTV-S/H7721 and GnTV-AS/H7721 cells using RT-PCR.
Fig. 3. Analysis of the expressions of four ST3Gals in GnTV-
S/H7721 and GnTV-AS/H7721 cells using RT-PCR.
Fig. 4. Western blot analysis and lectin staining of K2,3- and K2,6-
linked SA at the glycan termini of glycoproteins in GnTV-S/H7721
and GnTV-AS/H7721 cells.
Fig. 5. Analysis of C2GnT-I and C2GnT-II expressions in GnTV-
S/H7721 and GnTV-AS/H7721 cells using RT-PCR.
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explored the expressions of C2GnT-I and -II as two represen-
tatives of the C2GnT family with di¡erent substrate speci¢c-
ities.
In Fig. 5 the expressions of C2GnT-I and -II are shown as
determined by using RT-PCR. The products of C2GnT-I and
C2GnT-II were 692 and 180 bp, respectively, compatible with
earlier reports [22,23]. The expression of the former in H7721
cells was higher than the latter. The levels of C2GnT-I and -II
reduced to 45.5 and 54.0% of the ‘Mock’ value (P6 0.01) in
GnTV-S/H7721, and elevated to 190 and 160% of the ‘Mock’
level (P6 0.01) in GnTV-AS/H772 cells. Thus, the changes in
the expression levels closely correlated with those of K1,3-
FucTs.
4. Discussion
The ¢ndings in this study demonstrated that transfection of
sense and antisense cDNA of GnTV was accompanied by
changes in the expression levels of other glycosyltransferases
related to SLex synthesis. On the other hand, we have previ-
ously shown that there is an elevated metastatic potential in
the GnTV-transfected H7721 cells [7,8]. In the present study,
these cells showed a reduced expression of SLex on cell sur-
face, suggesting that SLex may not mediate the enhancement
of metastatic potential induced by GnTV-S. On the other
hand, GnTV transfection was associated with an elevated ex-
pression of ST3Gal-IV and an increased amount of terminal
K2,3-SA on the glycans of glycoproteins (Figs. 3 and 4), sug-
gesting that they could be important in mediating the en-
hanced metastatic capacity.
The decreased expression of SLex in GnTV-S-transfected
cells was accompanied by a reduction of K1,3-FucT-III, -VI,
-VII and C2GnT-I, -II, indicating a correlated role of these
two glycosyltransferase families in SLex synthesis. K1,3-FucT-
III, -VI, and -VII are directly involved in the last fucosylation
step in SLex synthesis. C2GnTs could increase the branching
of O-glycans, and in this way provide more substrate for K1,3-
FucT and ST3Gal to synthesize SLex. Our ¢ndings support
the results reported by Nakamura et al. [18] that SLex syn-
thesis in B lymphocyte leukemia cell line KM3 was critically
regulated by C2GnT-I. The present results showing that sur-
face SLex correlated with the expression of K1,3-FucT-III/-
VI/-VII in GnTV-S-, GnTV-AS- and mock-transfected cells
also implicate K1,3-FucT as another key enzyme for SLex
synthesis, such correlation is also seen in various cell lines
transfected with c-erbB2/neu or nm23H1 [15,17]. Collectively,
the downregulation of K1,3-FucT-III/-VI/-VII and C2GnT-I/
-II seems to underlie the reduced SLex expression on the
GnTV-S/H7721 cell surface. Conversely, the increased expres-
sions of K1,3-FucT-III/-VI/-VII and C2GnT-I/-II could pro-
vide an explanation for the elevation of SLex on GnTV-AS/
H7721 cells. Surprisingly, the change of ST3Gal-IV expression
in transfected cells was just the opposite to the alteration of
surface SLex on GnTV-S- and GnTV-AS-transfected cells.
This could suggest that ST3Gal-IV is not a rate-limiting en-
zyme in the synthesis of SLex. In GnTV-S/H7721 cells, in-
creased ST3Gal-IV could in principle provide more precursors
for fucosylation to be converted by K1,3-FucTs to SLex. The
fucosylation step, however, would be ine⁄cient due to reduc-
tion of K1,3-FucT-III/-VI/-VII in these cells. Moreover, the
downregulated C2GnTs would lead to a decrease in the C2
or C4 branching, thus reducing the substrates for terminal
sialylation and fucosylation. Collectively, this could provide
an explanation for the decrease of surface SLex on GnTV-
S/H7721 cells. The elevation of L1,6-GlcNAc branch in N-gly-
cans on GnTV-S/H7721 cell as shown previously in our lab [7]
may be not important in the change of total surface SLex,
since SLex mainly resides at the termini of O-glycans and
glycolipids. Similarly, a reduced number of antennary of N-
glycans and low level of ST3Gal-IV in GnTV-AS/H7721 cells
will not lead to reduction in the synthesis of SLex, since the
former is not important and the latter is not rate-limiting.
Furthermore, the increase of K1,3-FucT-III/-VI/-VII in
GnTV-AS/H7721 cells can promote the synthesis of SLex on
O-glycans and glycolipids. In addition, the upregulation of
C2GnTs further provides more branches on O-glycan and
increases the possibility for SLex synthesis. As a consequence,
SLex expression was increased on GnTV-AS/H7721 cells.
An interesting ¢nding was that there was an increase of
L1,6-GlcNAc branches in N-glycan in GnTV-S-transfected
cells and a concomitant decrease in L1,6-GlcNAc in O-gly-
cans. This occurred at the circumstance of a reduced
C2GnT expression. Conversely, a decrease of this branch in
N-glycan was seen in GnTV-AS-transfected cells accompanied
by an increase of L1,6-GlcNAc branch in O-glycans. The bio-
logical signi¢cance of the phenomenon is unknown and will
be further investigated.
In mock-transfected H7721 cells, the total expression of
ST3Gal-I^IV was far higher than the expression of ST6Gal,
but the content of K2,3-linked SA was lower than that of
K2,6-linked SA (Fig. 4). This may be partially explained by
that K2,6-SA is synthesized not only by ST6Gal, but also by
the ST6GalNAc family. It consists of I^VI subtypes, which
are the major enzymes for the K2,6-sialylation of O-glycans
[35,36]. The total activity of ST6GalNAc-I^VI plus ST6Gal
may exceed the total activity of ST3Gal-I^IV, resulting in the
higher content of K2,6-SA than of K2,3-SA.
The mechanism of the e¡ect of expressing sense or antisense
GnTV on the expression of other glycosyltransferases is un-
resolved and currently being investigated in our lab. Most
probably, however, the e¡ect is indirect. Concerning the pu-
tative pathways, we found that the GlcNAc-L1,6-mannose-
K1,6 branch of N-glycans on the receptor of epidermal growth
factor (EGF-R) was increased on GnTV-S/H7721 cells. This
altered glycosylation led to altered a⁄nity of EGF-R to EGF
and changes in transmembrane signal transduction, e.g.
changes in the activation of MAPK (mitogen-activated pro-
tein kinase) and protein kinase B signaling pathways. In
GnTV-AS/H7721 cells, the alterations were just opposite to
those in GnTV-S/H7721 (to be published). From these results,
we assume that the aberrantly glycosylated surface receptor
and the subsequent alterations in signal transduction from
some extracellular regulators to the genes of K1,3-FucTs,
ST3Gal-IV and C2GnTs could provide one possible mecha-
nism to explain the altered expression of these glycosyltrans-
ferases after GnTV-S or GnTV-AS transfection. In supporting
that, we discovered that transfection of GnTV-S and GnTV-
AS resulted in the alteration of the expression of integrin
genes [20], revealing that GnTV might indirectly regulate
some gene expressions. However, other mechanisms cannot
be ruled out, such as the multi-antennary glycan products of
GnTV protecting some regulatory factor(s) from degradation
by intracellular proteases, and the active factor(s) may a¡ect
the gene transcription of the glycosyltransferases.
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The expressions of other glycosyltransferases involved in
the synthesis of N-, O-glycans and glycolipids unrelated to
SLex synthesis may be also changed after transfection of
GnTV-S and GnTV-AS. It will be very interesting to further
study on this problem by using the gene chip of glycosyltrans-
ferases.
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